Evidence map›Paper›PMID 30642898›Full record

ArticleInfection and immunity2019

Structural and Functional Insights into PpgL, a Metal-Independent β-Propeller Gluconolactonase That Contributes to

Ying-Jie Song, Kai-Lun Wang, Ya-Lin Shen, Jie Gao, Tao Li, Yi-Bo Zhu, Chang-Cheng Li, Li-Hui He, Qiao-Xia Zhou, Ning-Lin Zhao and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. AlgU mediates hyperosmotic tolerance inApplied and environmental microbiology · 2024
    Article
  5. Prevalence ofBioMed research international · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 1 country.

Ying-Jie Song *Center of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Kai-Lun Wang *Center of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Ya-Lin ShenCenter of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Jie GaoCenter of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Tao LiCenter of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Yi-Bo ZhuCenter of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Chang-Cheng LiCenter of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Li-Hui HeCenter of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Qiao-Xia ZhouDepartment of Forensic Pathology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu, China.
Ning-Lin ZhaoCenter of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Chang ZhaoCenter of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Jing YangCenter of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Qin HuangCenter of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Xing-Yu MuCenter of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China.
Hong LiCenter of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China.
Deng-Feng DouHitGen Ltd., Chengdu, China.
Chuan LiuHitGen Ltd., Chengdu, China.
Jian-Hua HeShanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, China.
Bo SunShanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, China sunbo@sinap.ac.cn baorui@scu.edu.cn.
Rui BaoCenter of Infectious Diseases, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China sunbo@sinap.ac.cn baorui@scu.edu.cn.
Sichuan University · CNState Key Laboratory of BiotherapyChinese Academy of Sciences · CNShanghai Advanced Research Institute · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biofilm formation is a critical determinant in the pathopoiesis of

Indexed as

Bacterial ProteinsBiocatalysisBiofilmsCarboxylic Ester HydrolasesHeLa CellsHumansLactonesMetalsPeriplasmPseudomonas aeruginosaPseudomonas InfectionsSubstrate SpecificityVirulenceBacterial ProteinsCarboxylic Ester HydrolasesgluconolactonaseLactonesMetalsbiofilm formationnew drug targetPseudomonas aeruginosavirulenceβ-propeller

Identifiers

PMID30642898
PMCPMC6434122
OpenAlexW2910910851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.